Company intelligence / Profile preview

Michelle Rose, Inc.

Florida, United Statesmichellerose.com ↗

Ownership: Private
Development stage: Other

Overview

Michelle Rose, Inc. is a regulatory consulting firm founded by Dr. Michelle Rose after 20 years in the pharmaceutical and biotech industry. The company offers strategic regulatory advice to life science companies at all phases of drug development, including fast track development, accelerated approval pathways, special protocol assessments, breakthrough therapy designations, and new drug application (NDA) submissions under complex FDA rules such as the Animal Efficacy Rule[1][2][3]. There are no clinical results as it is a service provider.

Modalities: Small moleculeBiologic
Industry: Consulting

Beyond the preview

Go deeper on Michelle Rose, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Michelle Rose, Inc..

Explore the full profile